Rethinking cancer clinical trials for COVID-19 and beyond
The risks posed to patients with cancer by the current COVID-19 pandemic demand rapid structural changes in healthcare delivery, with many positive changes likely to continue long term. An immediate critical reassessment of trial methodology based on clinical and scientific priorities is essential t...
Saved in:
Published in | Nature cancer p. 1 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
01.06.2020
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | The risks posed to patients with cancer by the current COVID-19 pandemic demand rapid structural changes in healthcare delivery, with many positive changes likely to continue long term. An immediate critical reassessment of trial methodology based on clinical and scientific priorities is essential to ensure the resilience of clinical cancer research and optimize patient-centered care. |
---|---|
ISSN: | 2662-1347 |
DOI: | 10.1038/s43018-020-0083-x |